Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2012

Shareholders' Equity

Share-Based Activity

	Three Months Ended
	March 31,
	2012		2011
Share-based compensation expense	$	1,792	$	1,593
Fair value of shares vested		5,948		2,363
Cash received from option exercises		2,521		3,597
Tax benefit from option exercises		79		542

Schedule Of Changes In Non-Vested Restricted Shares

			Weighted
		Number	Average
		of	Grant
		Shares	Price
Non-vested shares at December 31, 2011		732,412	$	21.91
	Shares granted	255,138		22.66
	Shares vested	(166,078)		26.24
	Shares forfeited	(448)		24.75
Non-vested shares at March 31, 2012		821,024	$	22.36

Schedule Of Stock Option Activity

					Weighted
					Average
			Weighted		Remaining
		Number	Average		Contractual
		of	Exercise		Term
		Shares	Price		(in years)
Outstanding at December 31, 2011		2,510,054	$	23.09	3.4
	Options exercised with total intrinsic value of $2,521,000	(112,203)		22.47
Outstanding at March 31, 2012 with aggregate intrinsic value of $11,675,000		2,397,851	$	23.12	3.1
Vested at March 31, 2012 with aggregate intrinsic value of $11,675,000		2,397,851	$	23.12	3.1
Exercisable at March 31, 2012 with aggregate intrinsic value of $11,675,000		2,397,851	$	23.12	3.1

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

			Three Months Ended March 31,
						Per
			Earnings		Shares	Share
			(Numerator)		(Denominator)	Amount
2012:
Net earnings from continuing operations attributable to AmSurg Corp.
	per common share (basic)		$	15,719	30,619	$	0.51
Effect of dilutive securities options and non-vested shares				-	782
	Net earnings from continuing operations attributable to AmSurg Corp.
		per common share (diluted)	$	15,719	31,401	$	0.50
Net earnings attributable to AmSurg Corp. per common share (basic)			$	14,776	30,619	$	0.48
Effect of dilutive securities options and non-vested shares				-	782
	Net earnings attributable to AmSurg Corp.
		per common share (diluted)	$	14,776	31,401	$	0.47
2011:
Net earnings from continuing operations attributable to AmSurg Corp.
	per common share (basic)		$	11,605	30,420	$	0.38
Effect of dilutive securities options and non-vested shares				-	604
	Net earnings from continuing operations attributable to AmSurg Corp.
		per common share (diluted)	$	11,605	31,024	$	0.37
Net earnings attributable to AmSurg Corp. per common share (basic)			$	11,693	30,420	$	0.38
Effect of dilutive securities options and non-vested shares				-	604
	Net earnings attributable to AmSurg Corp.
		per common share (diluted)	$	11,693	31,024	$	0.38